American Board of Precision Medicine (ABOPM) shared on LinkedIn:
“Precision medicine doesn’t advance through technology alone. It advances through leadership.
The American Board of Precision Medicine is proud to welcome Emre B., as Chief Medical Officer, strengthening our commitment to advancing the clinical standards of precision medicine.
With expertise spanning precision oncology, molecular pathology, diagnostics, and translational cancer science, Dr. Baser brings a global perspective to the critical challenge of turning scientific discovery into meaningful, patient-centered care.
His leadership will help ABOPM continue building the education, certification, and clinical standards needed for the next era of medicine.
The future of medicine is precise. The standard must be, too.
Meet Dr. Baser and the leaders helping shape that future.
Other articles about Precision Medicine on OncoDaily.